Paul Yang

2.8k total citations
87 papers, 1.5k citations indexed

About

Paul Yang is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Yang has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 54 papers in Ophthalmology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Yang's work include Retinal Development and Disorders (55 papers), Retinal Diseases and Treatments (40 papers) and Retinal and Optic Conditions (17 papers). Paul Yang is often cited by papers focused on Retinal Development and Disorders (55 papers), Retinal Diseases and Treatments (40 papers) and Retinal and Optic Conditions (17 papers). Paul Yang collaborates with scholars based in United States, Brazil and United Kingdom. Paul Yang's co-authors include Mark E. Pennesi, Richard G. Weleber, C. Stephen Foster, B Jones, Leslie Henderson, Julian I. Schroeder, Shintaro Munemasa, Fernando Alemán, Elly Poretsky and Rainer Waadt and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Paul Yang

82 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Yang United States 24 747 721 297 176 155 87 1.5k
Manir Ali United Kingdom 24 654 0.9× 302 0.4× 356 1.2× 28 0.2× 277 1.8× 61 1.4k
Arnold Munnich France 25 1.6k 2.2× 237 0.3× 88 0.3× 61 0.3× 580 3.7× 55 2.3k
Robert B. Hufnagel United States 20 848 1.1× 307 0.4× 138 0.5× 28 0.2× 247 1.6× 97 1.3k
Brian P. Brooks United States 22 884 1.2× 253 0.4× 203 0.7× 20 0.1× 360 2.3× 73 1.4k
Naihong Yan China 17 611 0.8× 265 0.4× 134 0.5× 38 0.2× 151 1.0× 56 1.1k
Christian Hamel France 20 1.2k 1.7× 323 0.4× 87 0.3× 43 0.2× 265 1.7× 39 1.5k
Orly Goldstein United States 21 1.1k 1.5× 120 0.2× 62 0.2× 84 0.5× 446 2.9× 60 1.6k
John Danias United States 30 1.6k 2.1× 2.1k 2.9× 782 2.6× 16 0.1× 154 1.0× 73 3.3k
Adam S. Wenick United States 15 340 0.5× 733 1.0× 462 1.6× 29 0.2× 35 0.2× 27 1.3k
Donna S. Mackay United Kingdom 31 2.4k 3.2× 917 1.3× 174 0.6× 31 0.2× 897 5.8× 48 2.6k

Countries citing papers authored by Paul Yang

Since Specialization
Citations

This map shows the geographic impact of Paul Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Yang more than expected).

Fields of papers citing papers by Paul Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Yang. The network helps show where Paul Yang may publish in the future.

Co-authorship network of co-authors of Paul Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Yang. A scholar is included among the top collaborators of Paul Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Yang. Paul Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uner, Ogul E., Margaret Reynolds, Giacomo Maria Bacci, et al.. (2025). Phosphoribosyl pyrophosphate synthetase 1 ( PRPS1 ) associated retinal degeneration: an international study. Ophthalmic Genetics. 46(2). 133–143.
2.
Schmidt, Ryan, Austin D. Igelman, Aaron Nagiel, et al.. (2024). Refractive Error in Inherited Retinal Disease. American Journal of Ophthalmology. 269. 381–392. 2 indexed citations
3.
Yang, Paul, David G. Birch, Andreas Lauer, et al.. (2024). Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results. American Journal of Ophthalmology. 271. 268–285. 4 indexed citations
4.
Huang, Lingling, Paul Yang, Christina J. Flaxel, Eric B. Suhler, & Phoebe Lin. (2024). SUCCESSFUL TREATMENT OF CANCER-ASSOCIATED RETINOPATHY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOLLOWED BY A 0.18-MG FLUOCINOLONE IMPLANT WITHOUT SYSTEMIC IMMUNOSUPPRESSION. Retinal Cases & Brief Reports. 19(2). 214–220. 2 indexed citations
5.
Everett, Lesley, et al.. (2024). Using Multimodal Imaging to Refine the Phenotype of PRPH2-associated Retinal Degeneration. Ophthalmology Retina. 9(1). 69–77. 2 indexed citations
6.
7.
Igelman, Austin D., Cristy A. Ku, Lesley Everett, et al.. (2023). Expanding the phenotypic and genotypic spectrum of patients with HGSNAT -related retinopathy. Ophthalmic Genetics. 45(2). 167–174. 3 indexed citations
8.
Ku, Cristy A., et al.. (2023). Vitelliform maculopathy in MELAS syndrome. American Journal of Ophthalmology Case Reports. 30. 101842–101842. 1 indexed citations
9.
Wen, Shu, Meng C. Wang, Yumei Li, et al.. (2023). Systematic assessment of the contribution of structural variants to inherited retinal diseases. Human Molecular Genetics. 32(12). 2005–2015. 7 indexed citations
10.
Yang, Paul, Debarshi Mustafi, & Kathryn L. Pepple. (2023). Immunology of Retinitis Pigmentosa and Gene Therapy–Associated Uveitis. Cold Spring Harbor Perspectives in Medicine. 14(1). a041305–a041305. 5 indexed citations
11.
Vargas, Mauricio E., et al.. (2021). Variable expressivity of BEST1-associated autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a three-generation pedigree. BMJ Open Ophthalmology. 6(1). e000813–e000813. 3 indexed citations
12.
Scruggs, Brittni A., et al.. (2021). Injection pressure levels for creating blebs during subretinal gene therapy. Gene Therapy. 29(10-11). 601–607. 14 indexed citations
13.
Yang, Paul, Andreas Lauer, Mark E. Pennesi, et al.. (2021). Six Month Findings from a Phase 1/2 Clinical Study of Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa Show Clinically Meaningful Improvement in Macular Sensitivity. Investigative Ophthalmology & Visual Science. 62(8). 1481–1481. 4 indexed citations
14.
Ku, Cristy A., Austin D. Igelman, Andreas Lauer, et al.. (2021). Treatment outcomes in 11 patients with RPE65-retinopathy receiving voritegene neparvovec-rzyl. Investigative Ophthalmology & Visual Science. 62(8). 3320–3320. 1 indexed citations
15.
Gale, Michael J., Jenny L. Wilson, David M. Koeller, et al.. (2018). Longitudinal ophthalmic findings in a child with Helsmoortel-Van der Aa Syndrome. American Journal of Ophthalmology Case Reports. 10. 244–248. 6 indexed citations
16.
Yang, Paul, Aaron S. Coyner, Robert M. Duvoisin, et al.. (2018). Early Treatment with Mycophenolate Mofetil Reduces Retinal Degeneration and cGMP Dysregulation in rd10 and rd1 mice. Investigative Ophthalmology & Visual Science. 59(9). 2503–2503. 1 indexed citations
17.
Sullivan, Lori S., Sara J. Bowne, Daniel C. Koboldt, et al.. (2017). A Novel Dominant Mutation in SAG , the Arrestin-1 Gene, Is a Common Cause of Retinitis Pigmentosa in Hispanic Families in the Southwestern United States. Investigative Ophthalmology & Visual Science. 58(5). 2774–2774. 26 indexed citations
18.
Yang, Paul, et al.. (2016). Managing Intraoral Lesions in Oral Cancer Patients in a General Dental Practice: An Overview. Journal of the California Dental Association. 44(2). 85–92. 4 indexed citations
19.
Yang, Paul, et al.. (2013). Cellular Localisation and Functions of the ACE2 Metabolite of (Pyr1)apelin-13. Proceedings of The Physiological Society. 2 indexed citations
20.
Yang, Paul, B Jones, & Leslie Henderson. (2002). Mechanisms of anabolic androgenic steroid modulation of α1β3γ2L GABAA receptors. Neuropharmacology. 43(4). 619–633. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manir Ali Breakdown of academic impact, for papers by Arnold Munnich Breakdown of academic impact, for papers by Robert B. Hufnagel Breakdown of academic impact, for papers by Brian P. Brooks Breakdown of academic impact, for papers by Naihong Yan Breakdown of academic impact, for papers by Christian Hamel Breakdown of academic impact, for papers by Orly Goldstein Breakdown of academic impact, for papers by John Danias Breakdown of academic impact, for papers by Adam S. Wenick Breakdown of academic impact, for papers by Donna S. Mackay
Rankless by CCL
2026